First Horizon Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-63
Closed -$7K 2021
2020
Q4
$7K Sell
63
-200
-76% -$22.4K ﹤0.01% 1159
2020
Q3
$26K Buy
263
+200
+317% +$23K ﹤0.01% 743
2020
Q2
$8K Sell
63
-76
-55% -$8.62K ﹤0.01% 1082
2020
Q1
$12K Buy
139
+87
+167% +$9.21K ﹤0.01% 904
2019
Q4
$5K Hold
52
﹤0.01% 1288
2019
Q3
$6K Buy
52
+17
+49% +$2.58K ﹤0.01% 1230
2019
Q2
$6K Hold
35
﹤0.01% 1251
2019
Q1
$6K Buy
+35
New +$5.21K ﹤0.01% 1225

Other funds holding GWPH

First Horizon Advisors's GWPH Position: Q1 2021 in Review

First Horizon Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 63 shares — an estimated $7K sold.

First Horizon Advisors first reported a position in GWPH in Q1 2019 and held it in 8 quarters. The position peaked at $26K in Q3 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • First Horizon Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • First Horizon Advisors sold 63 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $7K.
  • First Horizon Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 8 quarters.
  • First Horizon Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $26K in Q3 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on First Horizon Advisors's 13F filing for Q1 2021, filed 11 May 2021.